(IGSB) 1-5 Year Investment Grade - Overview
Etf: Corporate Bonds, Investment Grade, 1-5 Year, Dollar-Denominated
Dividends
| Dividend Yield | 4.85% |
| Yield on Cost 5y | 5.02% |
| Yield CAGR 5y | 26.52% |
| Payout Consistency | 88.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 1.38% |
| Relative Tail Risk | -6.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 2.34 |
| Character TTM | |
|---|---|
| Beta | 0.024 |
| Beta Downside | 0.009 |
| Drawdowns 3y | |
|---|---|
| Max DD | 1.38% |
| CAGR/Max DD | 4.37 |
Description: IGSB 1-5 Year Investment Grade December 19, 2025
The iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) tracks an index of U.S.-dollar-denominated, investment-grade corporate bonds issued by both U.S. and non-U.S. companies, with remaining maturities between one and five years. The fund is required to hold at least 80 % of its assets in the index’s constituents and at least 90 % in fixed-income securities that BFA believes will enable effective tracking of the index.
Key quantitative points (as of the latest public data) include an expense ratio of 0.07 %, assets under management of roughly $5 billion, a weighted-average credit rating of AA, and a portfolio duration of about 2.8 years. The fund’s current weighted-average yield sits near 4.5 %, reflecting the higher compensation investors demand for short-term corporate credit relative to Treasury equivalents. Its sector composition is tilted toward financials and industrials, which together account for roughly 45 % of holdings, making the ETF sensitive to banking-sector health and industrial production trends.
Because IGSB’s performance is closely linked to short-term interest-rate expectations, monitoring the Federal Reserve’s policy stance and the shape of the yield curve is essential for assessing future price volatility.
For a deeper dive into the fund’s risk profile and comparative metrics, you might explore ValueRay’s analytics.
What is the price of IGSB shares?
Over the past week, the price has changed by +0.13%, over one month by +0.45%, over three months by +1.38% and over the past year by +6.78%.
Is IGSB a buy, sell or hold?
What are the forecasts/targets for the IGSB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 58.3 | 10.1% |
IGSB Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 21.64b USD (21.64b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 21.64b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 21.64b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.0% (E(21.64b)/V(21.64b) * Re(6.0%) + (debt-free company))
Discount Rate = 6.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)